Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PhRMA Anthrax Education Project Almost Ready; Lilly Launching CME Effort

Executive Summary

The Pharmaceutical Research & Manufacturers of America is about to begin a pilot project using member company sales forces to disseminate anthrax information to health professionals

You may also be interested in...



Rx Industry Will Sell Medicare Bill; Card Launch Will Be First Test

PhRMA's efforts to support the roll-out of the Medicare prescription drug benefit will begin with the use of industry sales reps to deliver educational material, incoming Pharmaceutical Research & Manufacturers of America Chairman Miles White (Abbott) told the association's annual meeting in Palm Beach, Fla. April 3

Rx Industry Will Sell Medicare Bill; Card Launch Will Be First Test

PhRMA's efforts to support the roll-out of the Medicare prescription drug benefit will begin with the use of industry sales reps to deliver educational material, incoming Pharmaceutical Research & Manufacturers of America Chairman Miles White (Abbott) told the association's annual meeting in Palm Beach, Fla. April 3

PhRMA Anthrax Brochure Includes Off-Label Information Disclaimer

The Pharmaceutical Research & Manufacturers of America's anthrax educational brochure includes a disclaimer that the information has not been approved by FDA

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS039265

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel